Association between lipids profile and thyroid parameters in euthyroid diabetic subjects: a cross-sectional study by unknown
Zhang et al. BMC Endocrine Disorders  (2015) 15:12 
DOI 10.1186/s12902-015-0008-3RESEARCH ARTICLE Open AccessAssociation between lipids profile and thyroid
parameters in euthyroid diabetic subjects:
a cross-sectional study
Yun Zhang1, Ping Lu1, Ling Zhang1 and Xinhua Xiao2*Abstract
Background: The concept is now emerging that higher thyroid-stimulating hormone (TSH) and lower thyroid hormone
levels within the euthyroid range may adversely affect atherosclerosis. The aim of this study was to investigate the
potential association between thyroid parameters and lipids profile in a cohort of euthyroid diabetic subjects.
Methods: Four hundred and sixty-two euthyroid type 2 diabetes subjects (302 males and 160 females) were consecutively
recruited. Clinical and anthropometric data was collected from all participants. Whole blood samples were drawn in
the morning after an overnight fasting for the measurement of serum TSH, free thyroxine (FT4), free triiothyronine
(FT3), anti-thyroid peroxidase antibody (TPO-Ab) levels, as well as lipid concentrations and glucose.
Results: TSH was higher in females than males. Stratified by TSH, high-density lipoprotein cholesterol (HDL-c) level
increased in subjects with TSH ≥2.5uIU/mL (P = 0.004). And TSH was associated with HDL-c in a Pearson correlation
test, however, the association failed to attain significance in partial correlation analyses, adjusted for age, sex, duration
of diabetes, fasting glucose and BMI. In females, total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c)
level was significant lower in subjects with TSH <2.5uIU/mL. TSH was significantly associated with TC and LDL-c, even
in a partial correlation analysis (P = 0.006 and 0.011, respectively). In a multiple linear regression analysis (stepwise), TSH
was positive associated with TC (β = 0.202, P = 0.005) and LDL-c (β = 0.144, P = 0.010). In one hundred and six patients
having TPO antibody assays, 6 (5.66%) were positive. The blood pressure and lipid levels were lower in TPO-Ab positive
patients, however, the differences were not significantly.
Conclusions: In conclusion, we identified TSH was positively associated with serum TC and LDL-c in euthyroid diabetic
women. Our analysis in the subgroup having TPO antibody assays demonstrating non-significantly lower TC levels among
seropositive subjects was consistent with the above stated consideration for women as a whole. Further investigations
are needed to understand the intimate mechanisms of lipid metabolism in type 2 diabetes with respect to
thyroid function.
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Thyroid hormones were recognized as catabolic hormones
and they regulated various processes of metabolism,
including the synthesis, mobilization, and breakdown of
lipids. Hypothyroidism had been reported to be associated
with an increased risk for dyslipidemia and atherosclerotic
cardiovascular disease [1,2]. Interestingly, the concept was* Correspondence: xiaoxinhua@medmail.com.cn
2Department of Endocrinology, Peking Union Medical College Hospital,
Chinese Academy of Medical Sciences & Peking Union Medical College,
100730 Beijing, P R China
Full list of author information is available at the end of the article
© 2015 Zhang et al.; licensee BioMed Central.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.emerging nowadays that effects of low thyroid function
on atherosclerosis susceptibility might extend into the
euthyroid range. Several studies reported an association
between higher thyroid-stimulating hormone (TSH) and
lower thyroid hormone levels that were still within the
normal range and lipids profile in the euthyroid popula-
tion [3,4].
Diabetes mellitus, in particular type 2 diabetes, which was
mostly associated with lipoid abnormalities [5], was also
known to dramatically increased risk of cardiovascular dis-
eases [6]. Notably, thyroid dysfunctions were more frequentThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Zhang et al. BMC Endocrine Disorders  (2015) 15:12 Page 2 of 5in diabetic patients than in the general population [7].
Moreover, the association between circulating TSH
levels and cardiovascular diseases risk factors seemed
to be amplified by the degree of insulin-resistance [8],
and it might be particularly relevant in type 2 diabetes.
Thus, glucose, lipids, and thyroid hormones seemed to
interact according to a more complex mathematical
function than as previously expected. Recently, several
studies had reported that even relative low thyroid
functions that were still within normal range were
more frequent and might be more dangerous in people
with diabetes [9-11]. However, only scanty studies on
these matters were available. And in most of these studies,
free triiodothyronine (FT3), free thyroxine (FT4) and TSH
were not measured together.
Taking into account the consideration mentioned above,
with the present study, we investigated the potential associ-
ation between TSH and thyroid hormones levels within the
normal range and lipids profile in a cohort of euthyroid
type 2 diabetes subjects. We hoped that the information
from this study would lead to a better understanding of the
relationship between thyroid parameters and lipids profile.
Methods
Subjects
Four hundred and sixty-two euthyroid type 2 diabetes
subjects (302 males and 160 females) were consecutively
recruited in this cross-sectional study from inpatients of
Department of Endocrinology, Henan Province People’s
Hospital. Type 2 diabetes was diagnosed according
to American Diabetes Association 2009 criteria [12].
Euthyroidism was defined as TSH, FT3, and FT4 levels
within their normal reference ranges (see the next
paragraph). Exclusion criteria: type 1 diabetes, latent
immune diabetes of the adults, gestational diabetes,
and other type of diabetes, pregnancy, neoplasms, as
well as any major medical condition in the 6 months
preceding the study (i.e. liver, kidney, and heart failure). In
particular, subjects with a previous history of thyroid
diseases, such as overt hyper/hypothyroidism, thyroid
cancer, were excluded. Subjects taking medications affect-
ing thyroid hormone levels (such as thyroid supplementa-
tion and antithyroid agents, IFNc, amiodarone, lithium,
corticosteroids, etc.) and lipids profile (such as statins,
fenofibrate, etc.) were also excluded. Informed consent
was obtained from all participants. The present study was
approved with the Institutional Ethnics Committee in
Zhengzhou University.
Clinical, anthropometric, and laboratory measurements
Clinical data was collected from all participants. Weight
and height were measured with the subjects wearing
light clothing and no shoes; the body mass index (BMI)
was also calculated (kg/m2). Whole blood samples weredrawn in the morning after an overnight fasting for mea-
surements of the study parameters. Serum TSH, FT3,
and FT4 levels were measured using chemiluminescence
tests (SIEMENS Advia Centaur XP). The normal ranges
were as follows: FT3 3.5-6.5pmol/L; FT4 11.5-22.7pmol/L;
TSH 0.55-4.78uIU/mL. Anti-thyroid peroxidase antibody
(TPO-Ab) was measured in 106 patients with agreement,
with reference values between 0 and 60U/L. The normal
range of all these thyroid parameters came from 1,000
normal controls determined before this study. And the
inter-assay and intra-assay imprecisions (CV) were all
less than 5%. Fasting plasma glucose (FPG) and lipid
concentrations (total cholesterol (TC), triglycerides (TG),
high-density lipoprotein cholesterol (HDL-c), and low-
density lipoprotein cholesterol (LDL-c)) were assayed using
enzymatic methods (Roche Diagnostics).
Statistical analyses
The data analysis was performed using SPSS version18.0.
All data was expressed as means ± standard deviation
(SD). All subjects were divided into two groups by sex
or TSH (≥2.5uIU/mL and <2.5uIU/mL). Student’s t test
or Mann–Whitney U test, depending on the shape of the
distribution curves, was used for evaluation of differences
between the two groups. The Pearson correlation test was
applied in order to assess for the existence of any significant
interdependence between numerical parameters. Partial
correlation analyses were performed to evaluate the
association of thyroid parameters with major cardio-
vascular risk factors (blood pressure and lipid concentra-
tions), adjusted for age, sex, duration of diabetes, FPG, and
BMI. Furthermore, we performed a multiple linear
regression analysis (stepwise) to confirm the associ-
ation, with cardiovascular risk factors as dependent
variables, independent variables as follows: age, sex,
BMI, duration of diabetes, FPG, FT3, FT4, TSH. Males
and females were analyzed separately. Subjects with
data of TPO-Ab were divided into two groups: TPO-
Ab positive (TPO-Ab >60U/L) and TPO-Ab negative
(TPO-Ab <60U/L), and differences between the two
groups were compared by t tests.
Results
Table 1 showed the clinical characteristics of this sample
of 462 diabetic patients with euthroidsm. The mean age
was 54.36 ± 11.85 years (range 27 to 84), and the mean
BMI was 25.33 ± 3.47 kg/m2 (range 17.5 to 37.2). Age and
TSH level were higher in females, and BMI, diastolic
blood pressure (DBP), and FT3 were lower. No difference
was found in FT4 or duration of diabetes.
Stratified by TSH, HDL-c level increased in subjects
with TSH ≥2.5uIU/mL (P = 0.004, Table 1). And TSH
was associated with HDL-c in a Pearson correlation test
(β = 0.095, P = 0.042), however, the association failed to
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Table 2), adjusted for age, sex, duration of diabetes, fasting
glucose and BMI.
In females, TC and LDL-c level was significant lower in
subjects with TSH <2.5uIU/mL (Table 1). TSH was signifi-
cantly associated with TC and LDL-c, even in a partial
correlation analysis (P = 0.006 and 0.011, respectively,
Table 2). In a multiple linear regression analysis (stepwise),
TSH was positive associated with TC (β = 0.202, P = 0.005)
and LDL-c (β = 0.144, P = 0.010). In males, no difference
was found in lipids profile or BP between subjects with
TSH ≥2.5uIU/mL and TSH <2.5uIU/mL group (Table 1).
In one hundred and six patients with TPO-Ab measured,
6 (5.66%) were positive and 100 (94.34%) were negative. In
TPO-Ab positive patients, SBP, DBP, FT3, TC, TG, HDL,
LDL levels were lower than TPO-Ab positive patients.
However, the differences were not significantly (Table 3).
Discussion
Thyroid dysfunction was a risk factor for cardiovascular
disease mediated by the effects of thyroid hormones on
lipids metabolism and blood pressure [13-15], yet most
subjects at risk for cardiovascular disease were euthyroid
in the clinical setting. The relationship between thyroid
hormones and atherosclerosis in the euthyroid population
had garnered much interest recently.
In this study, we demonstrated that TSH was higher in
females than males, which was in agreement with previous
studies [9]. Furthermore, we found that in diabetic females,
TC and LDL-c level was significant lower in subjects with
TSH <2.5uIU/mL. TSH was significantly associated with
TC and LDL-c, even in a partial correlation analysis. In aTable 1 Clinical characteristics of the subjects
Total Ma
n 462 302
Age(years) 54.36 ± 11.85 53.
Duration of diabetes(years) 8.33 ± 6.97 8.3
BMI (kg/m2) 25.33 ± 3.47 25.
FT3(pmol/L) 4.49 ± 0.49 4.6
FT4(pmol/L) 16.60 ± 2.29 16.







SBP(mmHg) 133.10 ± 14.54 133.52 ± 17.52 132
DBP(mmHg) 82.51 ± 8.89 82.41 ± 9.99 84.
TC (mmol/L) 4.88 ± 1.12 4.82 ± 1.06 4.6
TG (mmol/L) 2.04 ± 2.47 2.11 ± 1.81 2.3
HDL-c (mmol/L) 1.18 ± 0.30 1.09 ± 0.27* 1.1
LDL-c (mmol/L) 2.88 ± 0.84 2.90 ± 0.83 2.7
FBG (mmol/L) 8.55 ± 3.50 8.97 ± 3.74 8.5
*P < 0.05, when compared with TSH ≥ 2.5umIU/mL.multiple linear regression analysis (stepwise), TSH was
positive associated with TC and LDL-c. TSH levels within
the reference range had been reported to be associated
with serum lipid concentrations previously. Giandalia et al.
reported that TSH was associated with visceral obesity and
higher triglycerides concentration in type 2 diabetes [9].
And higher TSH was reported to confer increased
plasma cholesteryl ester transfer in the context of
chronic hyperglycemia in Triolo’s study [11]. All these
suggested that relatively low but clinically normal thyroid
function, as inferred from higher TSH in normal range,
could also influence lipids profile and atherosclerosis
susceptibility in type 2 diabetes.
One explanation to the positive association of TSH
with TC and LDL-c might be both being a consequence
of autoimmune activation involving lipoprotein(a), with
ensuing “reduced” lipoprotein(a) levels, a determinant of
new-onset diabetes, and accompanied by low circulating
TC and LDL-c and autoimmune complex involving
TSH as well. Among euthyroid patients with established
diabetes, the stated variables might tend to normalize
secondary to a decline in autoimmune processes and in
the reduction of lipoprotein(a) levels [16]. And lower TSH
in diabetic women associated with lower cholesterol could
be attributed to two phenomena: a) Lower TC and LDL-c
commonly precede autoimmune-initiated processes –be
it oxidatively-damaged TSH or rheumatoid arthritis
[17] or diabetes [18]; b) TSH incurring epitope damage
escapes immunoassay and is measured as “lower”.
Some authors suggested that chronic autoimmune
thyroiditis per se might be considered as a risk factor
of atherosclerosis independent of thyroid functionles Females
160
20 ± 11.87 56.56 ± 11.52
6 ± 7.10 8.27 ± 6.74
61 ± 3.10 24.80 ± 4.03
2 ± 0.49 4.24 ± 0.38
74 ± 2.27 16.34 ± 2.32









.86 ± 14.22 133.56 ± 18.04 133.43 ± 15.11 133.42 ± 16.45
14 ± 8.26 83.42 ± 10.27 80.29 ± 9.32 80.24 ± 9.03
7 ± 1.15 4.86 ± 1.12 5.16 ± 1.02 4.74 ± 0.92*
5 ± 3.13 2.29 ± 2.01 1.62 ± 0.94 1.72 ± 1.17
1 ± 0.28 1.07 ± 0.27 1.27 ± 0.31 1.14 ± 0.26
6 ± 0.85 2.95 ± 0.88 3.04 ± 0.81 2.81 ± 0.71*
1 ± 3.34 8.96 ± 3.84 8.60 ± 3.74 9.00 ± 3.52
Table 2 Correlation of thyroid parameters with lipids and blood pressure in Partial correlation analyses
FT3 FT4 TSH
coefficients P coefficients P coefficients P
Total SBP 0.027 0.566 −0.006 0.907 −0.026 0.588
DBP 0.035 0.453 −0.009 0.845 0.017 0.719
TC 0.012 0.794 0.010 0.835 0.044 0.352
TG 0.034 0.472 0.004 0.933 −0.003 0.948
HDL-c 0.044 0.347 0.033 0.484 0.079 0.092
LDL-c 0.001 0.978 −0.018 0.699 0.020 0.668
Males SBP 0.028 0.630 −0.043 0.466 −0.046 0.430
DBP 0.015 0.796 −0.032 0.582 0.000 0.999
TC −0.004 0.945 0.041 0.487 −0.059 0.317
TG 0.010 0.867 0.011 0.847 −0.043 0.467
HDL-c 0.007 0.900 0.083 0.154 0.062 0.288
LDL-c −0.008 0.885 −0.017 0.773 −0.080 0.171
Females SBP 0.022 0.787 0.064 0.433 0.001 0.992
DBP 0.103 0.206 −0.017 0.835 0.047 0.561
TC −0.010 0.905 −0.043 0.596 0.221 0.006*
TG 0.022 0.786 −0.051 0.530 0.050 0.537
HDL-c 0.147 0.069 −0.064 0.431 0.113 0.163
LDL-c −0.038 0.642 0.002 0.982 0.204 0.011*
*P < 0.05.
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first time in the association of thyroid function and
lipids profile and blood pressure in diabetic subjects.
Along with higher TSH and lower FT3 values in the
seropositive group, lower lipid concentrations and blood
pressure were observed, although the differences were not
significantly. The result did not support autoimmune
thyroiditis as a risk factor for atherosclerosis. ThisTable 3 Clinical characteristics of the subjects with data
of TPO-Ab
TPO-Ab negative TPO-Ab positive P
N(males/females) 100 (71/29) 6 (3/3)
Age(years) 52.71 ± 11.76 59.67 ± 10.03 0.160
BMI (kg/m2) 25.76 ± 3.38 23.17 ± 2.21 0.160
SBP (mmHg) 133.84 ± 16.99 126.00 ± 13.55 0.271
DBP (mmHg) 82.50 ± 9.68 77.83 ± 8.30 0.251
FT3(pmol/L) 4.54 ± 0.45 4.37 ± 0.45 0.353
FT4(pmol/L) 16.30 ± 2.16 16.69 ± 2.16 0.682
TSH(uIU/mL) 2.21 ± 1.13 2.49 ± 1.15 0.588
TC (mmol/L) 4.95 ± 1.15 4.30 ± 0.48 0.176
TG (mmol/L) 2.06 ± 2.05 1.59 ± 1.31 0.578
HDL-c (mmol/L) 1.17 ± 0.32 0.95 ± 0.27 0.099
LDL-c (mmol/L) 3.05 ± 0.94 2.75 ± 0.40 0.444
FBG (mmol/L) 8.40 ± 3.26 7.74 ± 5.48 0.647might result from the small sample size, only 6 patients
with TPO-Ab positive. Larger scale studies were needed
to further confirm the role of thyroid antibodies in
atherosclerosis.
Several methodological aspects and limitations of our
study needed to be considered. First of all, the causal
relationship could not be inferred from this study
because it was cross-sectional in nature. Secondly, in
type 2 diabetes patients, the relationship between thyroid
hormones and cardiovascular disease risk might be
influenced by other diabetes-related variables, such as
metabolic control, co-morbidities, and/or hypoglycemic
therapies. Strollo et al. found that TC and LDL-C corre-
lated negatively with FT4 and positively with FT3 only in
patients treated with insulin, but not in patients treated
with oral hypoglycaemic agents [19]. However, treatment
of diabetes was not considered in this study.
Conclusion
In conclusion, we identified TSH was positively associated
with serum TC and LDL-c in euthyroid diabetic women.
Our analysis in the subgroup having TPO antibody assays
demonstrating non-significantly lower TC levels among
seropositive subjects was consistent with the above stated
consideration for women as a whole. Further investi-
gations are needed to understand the intimate mecha-
nisms of lipid metabolism in type 2 diabetes with respect
to thyroid function.
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